Corvus Pharmaceuticals (CRVS)
(Delayed Data from NSDQ)
$5.91 USD
+0.30 (5.35%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $5.91 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.11 | 0.00% |
Earnings Summary
For their last quarter, Corvus Pharmaceuticals (CRVS) reported earnings of -$0.07 per share, beating the Zacks Consensus Estimate of $-0.12 per share. This reflects a positive earnings surprise of 41.67%. Look out for CRVS's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year increase of 8.33%.
Earnings History
Price & Consensus
Zacks News for CRVS
Here's Why Corvus (CRVS) is Poised for a Turnaround After Losing -25% in 4 Weeks
CRVS: What are Zacks experts saying now?
Zacks Private Portfolio Services